Exciting news！First commercial implantation of 聚脉® Drug-coated PTCA Balloon Dilatation Catheter
Mednovo's Drug coated PTCA balloon dilatation catheter（国械注准20233030115） achieved its first commercial implantation in The Third People Hospital of Chengdu after its recent NMPA approval.
Surgical information
Basic information of patients
A 68 years old woman, who suffered from repeated chest tightness for over a month, is initially diagnosed as chest tightness and hyperlipidemia. Angiography results show occlusion and subtotal occlusion of ostial anterior descending coronary artery. Her blood flood is restored after treated with 聚脉® Drug-coated PTCA Balloon Dilatation catheter.
Surgical image
Surgeon evaluation
Xia Long, a surgery expert, said: 聚脉® Drug-coated PTCA Balloon Dilatation catheter has great pushability which increases its crossability, it also demonstrates an excellent dilatation of the lesion.
Expert introduction
Secretary of Chengdu Chest Pain Alliance, member of Chengdu Coronary Pioneer, member of Sichuan Medical Health and Health Promotion Association, Secretary of National Health Commission Coronary Intervention Training Base. He is good at the clinical diagnosis and treatment of cardiovascular diseases, and has rich clinical experience in the diagnosis and treatment of common, frequently-occurring and difficult cardiovascular diseases.
聚脉®
With the continuous improvement of coronary interventional therapy and devices, its concept is also constantly evolving. "Nothing left", as a new concept of coronary interventional therapy is being accepted by more and more clinical physicians. And drug-coated balloon is the best scientific practice for it.
Independently developed by Hangzhou Revita Medical Technology Co., LTD., a subsidiary of Mednovo Group, 聚脉® is indicated for PTA for patients who suffered primary coronary artery stenosis or occlusion, with vessel diameter ≥2.0mm and ≤2.75mm. It received NMPA approval for marketing this February (国械注准20233030115).
聚脉® Drug-coated PTCA Balloon Dilatation catheter is used to dilate the stenosed coronary artery and improve myocardial blood flow. The best effect is achieved with the simplest method. The catheter is easy to operate and requires less procedure time. There is no implantation after intervention, and patients can still receive follow-up treatment.